Date | Compound | Laboratory | Indication | Type of Information |
---|---|---|---|---|
2012-04-06 | linsitinib | Astellas (Japan) | adrenal cortical carcinoma | |
2012-04-06 | antisense oligonucleotide targeted to the SMN2 gene | Isis USA Ltd (UK) | 5q spinal muscular atrophy | |
2012-04-06 | adenovirus-associated viral vector serotype 2 containing the human RPE65 gene | Alan Boyd Consultants Ltd (UK) | Leber’s congenital amaurosis | Granting of the orphan status in the EU |
2012-04-06 | genistein sodium salt dihydrate | Axcentua Pharmaceuticals (Sweden) | mucopolysaccharidosis type III (Sanfilippo syndrome) | |
2012-04-06 | dipalmitoylphosphatidylcholine, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol, sodium salt, synthetic surfactant protein C analogue and synthetic surfactant protein B analogue | Chiesi Farmaceutici (Italy) | respiratory distress syndrome in premature neonates of less than 37 weeks of gestational age | |
2012-04-11 | ziv-aflibercept | Sanofi (France) Regeneron Pharmaceuticals (USA) | metastatic colorectal cancer (mCRC) previously treated with an oxaliplatin-containing regimen |
Granting of a Market Authorisation in the EU |
2012-04-11 | (rotigotine transdermal system) | UCB (Belgium) | Parkinson’s Disease |
|
2017-09-14 | rivaroxaban | Bayer (Germany) |
|
Granting of a Market Authorisation in the EU |
2012-04-21 | pralatrexate | Allos Therapeutics (USA) | peripheral T-cell lymphoma |
Granting of a patent |
2012-04-26 | pridopidine, previously designated ACR16 | Neurosearch (Denmark) | Huntington's disease |
|
2012-04-27 | CGEN-15031 | Compugen (Israel) | autoimmune diseases | |
2012-04-27 | CGEN-15051 | Compugen (Israel) | rheumatoid arthritis, autoimmune diseases | |
2012-04-27 | CGEN-15001 | Compugen (Israel) | autoimmune diseases |
|
2012-04-27 | NHance™ technology (for therapeutics antibodies) | Argen-X (The Netherlands-Belgium) | ||
2014-12-01 | fluticasone propionate/formoterol fumarate | Napp Pharmaceuticals (UK) Skyepharma (UK) | asthma |
Product launch |
2012-04-27 | synthetic oligonucleotide | InDex Pharmaceuticals (Sweden) | steroid-resistant inflammatory diseases including inflammatory bowel disease, rheumatoid arthritis, psoriasis, asthma, emphysema and chronic obstructive pulmonary disease | |
2012-04-27 | everolimus | Novartis (Switzerland) | treatment of adult patients with kidney tumors known as renal angiomyolipomas and tuberous sclerosis complex (TSC), who do not require immediate surgery | Granting of a Market Authorisation in the US |
2012-04-27 | pazopanib | GSK (UK) | advanced soft tissue sarcoma |
Granting of a Market Authorisation in the EU |
2012-05-02 | EG013 | Ark Therapeutics (UK) | fetal growth restriction (FGR) | |
2012-05-02 | pasireotide | Novartis (Switzerland) | Cushing's disease |
Granting of a Market Authorisation in the US |
© 2024 Biopharmanalyses - Powered by Samacom+